Osteoinduction properties of different growth factors on cells from non-union patients: In vitro study for clinical application

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 1, 2010, Pages 51-62

  Gigante, Antonio ^a   Cappella, M ^a   Manzotti, S ^a   Cecconi, S ^a   Greco, F ^a   Primio, R D I ^a   Mattioli Belmonte, M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Non union; PRG; rhBPM 2; rhBPM 7

Indexed keywords

ASCORBIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLYCEROL 2 PHOSPHATE; GROWTH FACTOR; OSTEOCALCIN; OSTEONECTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT OSTEOGENIC PROTEIN 1; ALKALINE PHOSPHATASE; BMP2 PROTEIN, HUMAN; BMP7 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; GROWTH PROMOTOR; OSTEOGENIC PROTEIN 1; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOCHEMISTRY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; OSTEOBLAST; PSEUDARTHROSIS; THROMBOCYTE RICH PLASMA; ADULT STEM CELL; CYTOLOGY; DRUG EFFECT; FRACTURE HEALING; FRACTURE NONUNION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; ADULT STEM CELLS; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 7; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN TYPE I; COLLAGEN TYPE III; FEMALE; FRACTURE HEALING; FRACTURES, UNUNITED; GROWTH SUBSTANCES; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOBLASTS; OSTEOCALCIN; OSTEONECTIN; PLATELET-RICH PLASMA; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 77953723486     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: the diamond concept. Injury 2007; 38:S3-6.
2. Oreffo RO. Growth factors for skeletal reconstruction and fracture repair. Curr Opin Investig Drugs 2004; 5:419-23.
3. Giannoudis PV, Tzioupis CC, Tsiridis E. Gene therapy in orthopaedics. Injury 2006; 37:30-40.
4. Lieberman JR, Daluiski A, Einhorn TA. Current concepts review. The role of growth factors in the repair of bone. J Bone Joint Surg (Am) 2002; 84: 1032-44.
5. Gigante A, Chillemi C, Greco F. Bone morphogenetic proteins in the repair of articular cartilage lesions: Experimental studies and clinical application. In Advances In Skeletal Reconstruction Using Bone Morphogenetic Proteins. T.S. Lindholm ed. World Scientific Publ. Co. Singapore 2002; p204.
6. Mattioli-Belmonte M, Gigante A, Muzzarelli RA, Politano R, De Benedittis A, Specchia N, Buffa A, Biagini G, Greco F. N,N-dicarboxymethyl chitosan as delivery agent for bone morphogenetic protein in the repair of articular cartilage. Med Biol Eng Comput 1999; 37:130-4
7. Saito N, Murakami N, Takahashi J, Horiuchi H, Ota H, Kato H, Okada T, Nozaki K, Takaoka K. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv Drug Deliv Rev 2005; 57:1037-48.
8. Robinson Y, Heyde CE, Tschöke SK, Mont MA, Seyler TM, Ulrich SD. Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery. Expert Rev Med Devices 2008; 5:75-84.
9. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg (Br) 1999; 81:710-18.
10. Kanakaris NK, Paliobeis C, Nlanidakis N, Giannoudis PV. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury 2007; 38:65-75.
11. Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg (Am) 2001; 83:151-8.
12. Bielecki T, Gazdzik TS, Szczepanski T. Re: "The effects of local platelet rich plasma delivery on diabetic fracture healing". What do we use: Platelet-rich plasma or platelet-rich gel? Bone 2006; 39: 1388.
13. Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 2002; 18:27-33.
14. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR: Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:638-46.
15. Gandhi A, Doumas C, O'Connor JP, Parsons JR, Lin SS. The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 2006; 38:540-6.
16. Bolander ME. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1992; 200:165-70.
17. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Periodontol 2000; 71:1654-61.
18. Froum SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 2002; 22:45-53.
19. Aghaloo TL, Moy PK, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study. J Oral Maxillofac Surg 2002; 60:1176-81.
20. Soffer E., Ouhayoun JP, Dosquet C, Meunier A, Anagnostou F. Effect of platelet lysates on selected bone cell functions. Clin Oral Implantol Res 2004; 15:581-88. (Pubitemid 40104954)
21. Dominici M, Le Blanc K, Mueller I, et al. Minimal Criteria for defining multipotent mesenchymal stem cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315-17.
22. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995; 3:655-9.
23. St John TA, Vaccaro AR, Sah AP, Schaefer M, Berta SC, Albert T, Hilibrand A. Physical and monetary costs associated with autologous bone graft harvesting. Am J Orthop 2003; 32:18-23.
24. Johnson KD, Frieson KE, Keller TS, Cook C, Scheinberg R, Zerwekh J, Meyers L, Scialdini MF. Porous ceramics as bone graft substitutes in long bone defects: A biochemical, histological, and radiographic analysis. J Orthop Res 1996; 14:351-69.
25. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. Application of recombinant BMP-7 on persistent upper and lower limb nonunions. Injury 2005; 36:51-9.
26. Schmidmaier G, Schwabe P, Strobel C, Wildemann B. Carrier systems and application of growth factors in orthopaedics. Injury 2008; 39:37-43.
27. Gigante A, Bevilacqua C, Cappella M, Greco F. Bone morphogenetic protein-7 nel trattamento delle pseudoartrosi: indicazioni e limiti. GIOT 2004; 30: 125-8.
28. Hietaniemi K, Lehto MU, Paavolainen P. Major fibrillar collagens and fibronectin in an experimental nonunion: an immunohistochemical study. Acta Orthop Scand 1998; 69:545-9.
29. Hietaniemi K, Paavolainen P, Penttinen R. Connective tissue parameters in experimental nonunion. J Orthop Trauma 1996; 10:114-8.
30. Guerkov HH, Lohmann CH, Liu Y, Dean DD, Simon BJ, Heckman JD, Schwartz Z, Boyan BD. Pulsed electromagnetic fields increase growth factor release by nonunion cells. Clin Orthop Relat Res 2001; 384: 265-79.
31. Kloen P, Doty SB, Gordon E, Rubel IF, Goumans MJ, Helfet DL. Expression and activation of the BMP-signaling component in human fracture nonunions. J Bone Surg 2002; 84:1909-18.
32. Meyer RA, Meyer MH, Phieffer LS, Banks DM. Delayed union of femoral fractures in older rats: decreased gene expression. BMC Musculoskelet Disord 2001; 2:2.
33. Desai BJ, Meyer MH, Porter S, Kellam JF, Meyer RA Jr. The effect of age on gene expression in adult and juvenile rats following femoral fracture. J Orthop Trauma 2003; 17:689-98.
34. Brownlow HC, Simpson AH. Metabolic activity of a new atrophic nonunion model in rabbits. J Orthop Res 2000; 18:438-42.
35. Boyan BD, Schwartz Z, Swain LD, Khare AG, Heckman JD, Ramirez V, Peters P, Carnes DL Jr. Initial effects of partially purified bone morphogenetic protein on the expression of glycosaminoglycan, collagen, and alkaline phosphatase in nonunion cell cultures. Clin Orthop Relat Res 1992; 278:286-304.
36. Qu G, von Schroeder HP. The osteogenic potential of pseudoarthrosis tissue and bone from human scaphoid non-unions. J Hand Surg Eur 2008; 33:449-56.
37. Asahina I, Sampath T, Hauschka P. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996; 222:38-47.
38. Wozney JM. Overview of bone morphogenetic proteins. Spine 2002; 27:2-8.
39. Marrony S, Bassilana F, Seuwen K, Keller H. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 2003; 33: 426-33.
40. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995; 13:655-63.
41. Lucarelli E, Beccheroni A, Donati D, et al. Platelet derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003; 18: 3095-100.
42. Slapnicka J, Fassmann A, Strasak L, Augustin P, Vanek J. Effects of activated and nonactivated platelet-rich plasma on proliferation of human osteoblasts in vitro. J Oral Maxillofac Surg 2008; 66: 297-301.
43. Ferreira CF, Carriel Gomes MC, Filho JS, Granjeiro JM, Oliveira Simões CM, Magini Rde S. Platelet-rich plasma influence on human osteoblasts growth. Clin Oral Implants Res 2005; 16:456-60.
44. Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006; 17:212-9.
45. Roldán JC, Jepsen S, Miller J, Freitag S, Rueger DC, Açil Y, Terheyden H. Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 2004; 34:80-90.
46. Tomoyasu A, Higashio K, Kanomata K, et al. Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs. Biochem Biophys Res Commun 2007; 361:62-7.
47. Jung RE, Schmoekel HG, Zwahlen R, Kokovic V, Hammerle CH, Weber FE. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2. Clin Oral Implants Res 2005; 16:676-82. (Pubitemid 43951429)